England Cricket Board (ECB) on Friday announced that the fifth Test between India and England, which was suspended due to a COVID-19 outbreak last month, is rescheduled to July next year. The rescheduled test will now be held at Edgbaston from July 1-5 and will be followed by a three-match T20I and ODI series.
“With India leading the series 2-1, the concluding fifth match will now take place from July 1, 2022, at Edgbaston. Following an agreement between the England and Wales Cricket Board (ECB) and the Board of Control for Cricket in India (BCCI),” said the ECB in a statement.
The three-match T20 series will begin on July 7 at Ageas Bowl. Edgbaston and Trent Bridge will be hosting the second and third games on July 9 and 10 respectively. The ODI series starts on July 12 at The Oval. The Lord’s will host the second game on July 14 and the series will conclude at Old Trafford on July 17.
“Ticket holders do not have to take any action as all tickets will remain valid for the equivalent rearranged matchday at their host venue,” the ECB said.
“Host venues will communicate the new fixture details to ticket purchasers. And the options available to them. Including the timeframe for requesting a refund if they are not able to attend the new match day,” it added.
“I am happy that the England-India Test series will now have its rightful conclusion. The four-Test matches were riveting, and we needed a fitting finale. The BCCI recognizes and respects the traditional form of the game and is also mindful of its role and obligations towards fellow Board Members.” BCCI secretary Jay Shah said in a statement
Rescheduled fifth Test, Edgbaston – 1-5 July
1st T20I, Ageas Bowl – 7 July
2nd T20I, Edgbaston – 9 July
3rd T20I, Trent Bridge – 10 July
1st ODI, The Oval – 12 July
2nd ODI, Lord's – 14 July
3rd ODI, Old Trafford – 17 July
IND vs ENG
Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.